Enobia Provides Update On Progress With ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia
Links shared publicly online about this topic.
- 886total visits
Enobia Provides Update On Progress With ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia
Enobia Pharma provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of
View full resource at medicalnewstoday.com
Tags: Pharma
Most Recently Shared on September 9, 2010 at 7:00 pm By:
Enobia Provides Update On Progress With ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia http://mnt.to/3Jvh
Also Shared By:
Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients
news-medical.net — “Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.” View full resource at news-medical.net
Most Recently Shared on September 8, 2010 at 1:27 pm By:
Genetics News: Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients: Enobia Pharma to... http://buzzup.com/19g3w
Advertisement
MNT Bones/Orthopedic
@mnt_bones
Enobia Provides Update On Progress With ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia http://mnt.to/3Jvh
1 year ago...